cGAS/STING pathway in microglial diseases In the context of neurodegeneration, amplification of microglial cGAS-STING signaling, along with IFN production and cGAS-driven senescence, has been implicated as a disease-promoting mechanism in female mice ( R47H variant, indicating both associated with increased risk and earlier onset of Alzheimer's disease and their potential role as upstream modulators of AD pathogenesis (Yu et al., 2020)
Its low molecular weight (~340 Da) means it reaches tissue compartments that larger peptides may not, and its stability profile is well-suited to combination formulations
Because the ratio is fixed inside the vial, the 330 mcg total splits evenly into roughly 165 mcg of each peptide you cannot tune one without the other, which is exactly why the blend is described as a single, self-contained stack
The peptide appears to influence slow-wave sleep (SWS) promotion while simultaneously modulating hypothalamic-pituitary-adrenal (HPA) axis activity and reducing stress hormone levels
In a longitudinal study, having a hospital diagnosis of a MA-related condition was associated with an approximately fivefold risk of all-cause mortality compared to that in the general population (4)
R.Hojjati KermaniM
